Search
Close this search box.
Search
Close this search box.

November 20, 2024

Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination With KEYTRUDA(R) (pembrolizumab), Met Primary Efficacy Endpoint in Phase 2b KEYNOTE-942 Trial

mRNA-4157/V940, in combination with KEYTRUDA, demonstrated a statistically significant and clinically meaningful reduction in the risk of disease recurrence or death compared to KEYTRUDA monotherapy in stage III/IV melanoma patients with high risk of recurrence following complete resection Results are the first demonstration of efficacy for an investigational mRNA cancer

Deriv global offices certified as a Great Place to Work® for 2022-23

Celebrating achievements in Deriv’s office in Malaysia Cyberjaya, MALAYSIA, Dec. 13, 2022 (GLOBE NEWSWIRE) — Deriv, one of the world’s largest online brokers, once again proved that great work challenges and dynamic work culture are the driving force behind its global success. Cyberjaya, Dubai, Asuncion, Minsk, Birkirkara, Limassol, Kigali, Ipoh,

ROSEN, A TOP RANKED LAW FIRM, Encourages Singularity Future Technology Ltd. f/k/a Sino-Global Shipping America Ltd. Investors to Secure Counsel Before Important Deadline in First Filed Securities Class Action Initiated by the Firm – SGLY

NEW YORK, Dec. 12, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Singularity Future Technology Ltd. f/k/a Sino-Global Shipping America Ltd. (NASDAQ: SGLY) between February 12, 2021 and

PM congratulates Prince Karim Aga Khan IV on his birthday

Prime Minister Shehbaz Sharif has congratulated Prince Karim Aga Khan IV on his birthday.In a tweet on Tuesday, he said we acknowledge, appreciate and remain grateful for his wonderful contributions to the cause of education and socio-economic developm…

RECENT NEWS

Copyright © 2024 Pakistan Press Release Point. All rights reserved.